Intellia Therapeutics, Inc. (NTLA): 4 filed Mar 3, 2026

Form type

4

Filing date

Mar 3, 2026

Accession number

0001193125-26-088258

Filer

Intellia Therapeutics, Inc. (CIK 1652130)